dr. neelapu on zuma-1 trial design of kte-c19
Published 7 years ago • 121 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
2:24
dr. neelapu on axi-cel in the zuma-1 trial for refractory aggressive non-hodgkin lymphoma
-
1:13
dr. neelapu on primary results of the zuma-1 trial in nhl
-
1:18
dr. neelapu on the safety profile of kte-c19 in patients with lymphoma
-
0:53
dr. neelapu on next steps with kte-c19 in lymphoma
-
1:34
dr. neelapu on interim results of the phase ii zuma-1 study in dlbcl
-
2:02
dr. neelapu on updated zuma-1 findings in non-hodgkin lymphoma
-
0:53
design of the zuma-1 trial in non-hodgkin lymphoma
-
2:24
zuma-1: a pivotal trial of axicabtagene ciloleucel (axi-cel; kte-c19) in patients with nhl
-
15:12
understanding type 1 diabetes - jumo health
-
22:38
introduction to haematology part 1
-
53:24
cellular adaptations chapter#1/part#01 pathoma review | dr zabiullah
-
1:03
sattva neelapu, md, discusses the results of the zuma-1 pivotal phase 2 study with kte-c19
-
1:14
results of the zuma-1 trial exploring kte-c19 in nhl
-
3:41
interim results from the zuma-1 trial of novel car-t cells against non-hodgkin lymphoma
-
3:31
zuma-1 trial observations
-
8:01
high-risk lymphoma: the zuma-1 and scholar-1 trials
-
1:23
dr. locke on the zuma-i trial of kte-c19
-
4:19
the pivotal zuma-1 trial for nhl
-
2:59
axi-cel in older patients: data from zuma-1 and clinical use
-
3:32
zuma-1: updated data and future prospects
-
6:03
clinical data for axi-cel in lymphoma